Suppr超能文献

全国接种疫苗对朝鲜 COVID-19 疫情结果的可能影响:建模研究。

The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study.

机构信息

Kyoto University School of Public Health, Kyoto, Japan.

Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea.

出版信息

J Korean Med Sci. 2022 Oct 24;37(41):e300. doi: 10.3346/jkms.2022.37.e300.

Abstract

BACKGROUND

The Democratic People's Republic of Korea (North Korea) had successfully suppressed the coronavirus disease 2019 (COVID-19) epidemic via border closures. However, a rapid surge in incidence was reported due to the spread of the omicron variant (B.1.1.529), leading to a national emergency declaration in May 2022. Moreover, with the lack of vaccine accessibility and medical facilities, it is unclear how the disease burden may be exacerbated. Despite the limited epidemiological data, we aimed to project the COVID-19 transmissions in North Korea and quantify the potential impact of nationwide vaccination, comparing epidemiological outcomes via scenario analysis.

METHODS

A discrete-time deterministic compartmental model was used. The parameters were calibrated using empirical data. Numerical simulations incorporated nationwide COVID-19 vaccination into the proposed model with various asymptomatic proportions.

RESULTS

Our model suggested that the stringent public health and social measures (PHSMs) reduced the severe acute respiratory syndrome coronavirus 2 transmissibility by more than 80% in North Korea. Projections that explicitly incorporated vaccination indicated that nationwide vaccination would be necessary to suppress a huge resurgence in both COVID-19 cases and hospitalizations after the stringent PHSMs are eased. Moreover, vaccinating more than 80% of the population with two doses may keep the peak prevalence of hospitalizations below 1,500, averting more than 40,000 hospitalizations across all scenarios.

CONCLUSION

Nationwide vaccination would be essential to suppress the prevalence of COVID-19 hospitalizations in North Korea after the stringent PHSMs are lifted, especially in the case of a small asymptomatic proportion.

摘要

背景

朝鲜民主主义人民共和国(朝鲜)通过关闭边境成功抑制了 2019 年冠状病毒病(COVID-19)疫情。然而,由于奥密克戎变异株(B.1.1.529)的传播,发病率迅速上升,并于 2022 年 5 月宣布国家进入紧急状态。此外,由于疫苗可及性和医疗设施的缺乏,尚不清楚疾病负担可能会如何加重。尽管流行病学数据有限,但我们旨在预测朝鲜的 COVID-19 传播,并通过情景分析量化全国接种疫苗的潜在影响。

方法

使用离散时间确定性 compartmental 模型。使用经验数据对参数进行校准。数值模拟将全国性 COVID-19 疫苗接种纳入提出的模型中,并结合各种无症状比例进行了流行病学结果的比较。

结果

我们的模型表明,严格的公共卫生和社会措施(PHSMs)使朝鲜的严重急性呼吸综合征冠状病毒 2 传染性降低了 80%以上。明确纳入疫苗接种的预测表明,在严格的 PHSMs 放宽后,全国范围内接种疫苗对于抑制 COVID-19 病例和住院人数的巨大反弹是必要的。此外,接种两剂疫苗的人口超过 80%可能会将住院高峰期的流行率保持在 1500 以下,避免所有情景下超过 40000 例住院。

结论

在严格的 PHSMs 放宽后,全国范围内接种疫苗对于抑制朝鲜 COVID-19 住院人数至关重要,尤其是在无症状比例较小的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b08/9592938/ea940c4ad885/jkms-37-e300-g001.jpg

相似文献

3
North Korean health at risk due to border closures.
Lancet. 2021 Jul 3;398(10294):13. doi: 10.1016/S0140-6736(21)01456-2.
4
Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
Epidemics. 2022 Sep;40:100618. doi: 10.1016/j.epidem.2022.100618. Epub 2022 Jul 27.
7
Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based Analysis.
J Korean Med Sci. 2022 Jun 13;37(23):e189. doi: 10.3346/jkms.2022.37.e189.
8
Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
Epidemiol Health. 2021;43:e2021040. doi: 10.4178/epih.e2021040. Epub 2021 May 27.
9
Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy.
J Korean Med Sci. 2015 Nov;30(11):1584-8. doi: 10.3346/jkms.2015.30.11.1584. Epub 2015 Oct 16.
10
North Korea's COVID-19 policy dilemma: epidemic prevention conflicting with trade.
Global Health. 2024 Jan 16;20(1):8. doi: 10.1186/s12992-023-01013-9.

引用本文的文献

1
Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia.
Front Public Health. 2023 Sep 25;11:1252719. doi: 10.3389/fpubh.2023.1252719. eCollection 2023.

本文引用的文献

1
Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
Epidemics. 2022 Sep;40:100618. doi: 10.1016/j.epidem.2022.100618. Epub 2022 Jul 27.
2
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England.
Lancet Infect Dis. 2022 Jul;22(7):931-933. doi: 10.1016/S1473-3099(22)00309-7. Epub 2022 May 24.
4
COVID-19: the next phase and beyond.
Lancet. 2022 May 7;399(10337):1753. doi: 10.1016/S0140-6736(22)00817-0.
5
China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
J Infect. 2022 Jul;85(1):e13-e14. doi: 10.1016/j.jinf.2022.04.025. Epub 2022 Apr 18.
6
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea.
Epidemiol Health. 2022;44:e2022034. doi: 10.4178/epih.e2022034. Epub 2022 Mar 12.
7
8
High Asymptomatic Carriage With the Omicron Variant in South Africa.
Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.
9
Daily briefing: 'Out of control' Omicron threatens China.
Nature. 2022 Mar 28. doi: 10.1038/d41586-022-00902-0.
10
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验